《滬深兩市》上證深成半日跌0.2%至0.6% 醫藥股造好
內地昨日(29日)新增97宗本土新冠肺炎確診病例,625宗本土無症狀感染者。人民銀行今日(30日)開展1,280億元人民幣(下同)7天期及580億元14天期逆回購操作,單日淨投放1,840億元,中標利率持平。人民幣兌美元中間價上調104點。內地9月官方製造業PMI升至50.1,市場預期49.7,並與9月財新製造業PMI降至48.1的數據不一致。上證深成微微高開後倒跌,半日跌0.2%至0.6%。
上證半日跌6點或0.2%,報3,034點;深成指跌60點或0.6%,報10,859點;創業板指數跌21點或0.9%,報2,311點。上證、深成及創板半日成交分別爲1,409億、1,960億及612億元。
中資金融股靠穩,工行(601398.SH)升0.5%,建行(601939.SH)反覆靠穩。
內房股上揚,東旭藍天(000040.SZ)漲停,華聯控股(000036.SZ)升6.7%。人行及中銀保監階段性放寬部分城市首套住房貸款利率下限,推動「保交樓」專項借款加快落地使用並視需要適當加大力度。
醫藥股造好,力生製藥(002393.SZ)、華森製藥(002907.SZ)及龍津藥業(002750.SZ)漲停。由湖北、北京及河北等多個聯盟地區近日委派代表組成的全國中成藥聯合採購辦公室成立,《全國中成藥聯盟採購公告》也同步發佈,是次國採涉及多個獨家品種。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.